Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award President and CEO acquired 6,667 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 27,027 shares (grant or award)
  7. 4 Open-market sale 10% owner sold 10,000 shares at $2.31 ($23,100)
  8. 4 Grant or award President and CEO acquired 7,440 shares (grant or award)
  9. 4 Grant or award President and CEO acquired 6,693 shares (grant or award)
  10. 4 Open-market sale 10% owner sold 10,000 shares at $2.04 ($20,400)
  11. 4 Grant or award President and CEO acquired 8,503 shares (grant or award)
  12. 4 Open-market sale Director sold 60,000 shares at $2.17 ($130,200)
  13. 4 Grant or award President and CEO acquired 7,610 shares (grant or award)
  14. 4 Open-market sale 10% owner sold 10,000 shares at $2.23 ($22,300)
  15. 4 Grant or award President and CEO acquired 7,440 shares (grant or award)
  16. 4 Grant or award President and CEO acquired 6,614 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 6,410 shares (grant or award)
  18. 4 Grant or award President and CEO acquired 6,061 shares (grant or award)
  19. 4 Grant or award President and CEO acquired 6,562 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 5,807 shares (grant or award)

Page 14 of 39 · 776 filings